Eris Lifesciences betting on insulin expertise to boost its GLP-1 play

Eris Lifesciences is using its growing insulin business to position itself as a serious contender in India’s fast-expanding diabetes and obesity drug market.

​Eris Lifesciences is using its growing insulin business to position itself as a serious contender in India’s fast-expanding diabetes and obesity drug market.